SCHEMBL3603279

SCHEMBL3603279

COc1ccc(COc2cc(Oc3c(/C=C/C4(O)CC4)c(C)nn3C)c(Cl)cc2Cl)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.38
CYP1A2 P05177 3/20 0.35
CYP2C9 P11712 3/20 0.35
CYP2C19 P33261 3/20 0.35
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
LMNA P02545 2/20 0.35
CASP3 P42574 1/20 0.34
KMT2A Q03164 1/20 0.34
SENP8 Q96LD8 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
HDAC8 Q9BY41 1/20 0.32
FPR2 P25090 2/20 0.32
PROKR1 Q8TCW9 2/20 0.32
HSP90AA1 P07900 1/20 0.31
HSP90AB1 P08238 1/20 0.31
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3603282 1.00 GAA (0.38) GAACYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL3607405 0.84 ALDH1A1 (0.42) GAACYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL3607401 0.84 ALDH1A1 (0.42) GAACYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL3612420 0.84 SMN1; SMN2 (0.53) GAACYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL3604681 0.84 SMN1; SMN2 (0.40) GAACYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL3605154 0.82 ALDH1A1 (0.38) CYP1A2CYP2C9CYP2C19ALDH1A1KDM4E
SCHEMBL3605148 0.82 ALDH1A1 (0.38) CYP1A2CYP2C9CYP2C19ALDH1A1KDM4E
Hydrochloric Acid SCHEMBL3614835 0.81 ALDH1A1 (0.37) CYP1A2CYP2C9CYP2C19ALDH1A1KDM4E
Hydrochloric Acid SCHEMBL3614837 0.81 ALDH1A1 (0.37) CYP1A2CYP2C9CYP2C19ALDH1A1KDM4E
SCHEMBL3607959 0.80 GAA (0.38) GAACYP1A2CYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100016396-A1 PYRAZOLE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100016396-A1 PYRAZOLE COMPOUND SLC5A1, SLC5A2, GLP1R GAA 405/4885CYP1A2 137/4885CYP2C9 145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.